Tazidime and Xopenex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazidime (ceftazidime) and Xopenex (levalbuterol hydrochloride). Common drug interactions include dysphagia among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Tazidime and Xopenex. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

On Aug, 03, 2026

16 people who take Tazidime and Xopenex together, and have interactions are studied.

What are the common drug interactions of Tazidime and Xopenex, by gender? *:

female:

Dysphagia (a condition in which swallowing is difficult or painful)
Dysuria (painful or difficult urination)
Impaired gastric emptying
Multi-organ failure (multisystem organ failure)
Nausea (feeling of having an urge to vomit)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Renal impairment (severely reduced kidney function)
Salivary gland enlargement (increased size of salivary gland)
Sepsis (a severe blood infection that can lead to organ failure and death)

male:

Insomnia (sleeplessness)
Abdominal discomfort
Lung disorder (lung disease)
Lung infection
Malaise (a feeling of general discomfort or uneasiness)
Migraine (headache)
Multiple allergies (allergy to multiple agents)
Obesity (having too much body fat)
Oedema (fluid collection in tissue)
Polycystic ovaries (cysts in the ovaries that occurs when the follicle stops developing)

What are the common drug interactions of Tazidime and Xopenex, by age (0-1 to 60+)? *:

0-1:

Hypercapnia (too much smoke)
Oxygen saturation decreased

2-9:

Multi-organ failure (multisystem organ failure)
Sepsis (a severe blood infection that can lead to organ failure and death)
Altered state of consciousness (altered state of mind)
Hydrocephalus (water on the brain)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Disseminated intravascular coagulation (systemic activation of blood coagulation)

10-19:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Pneumonia

20-29:

Chest pain
Pyrexia (fever)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anaemia (lack of blood)
Bacterial test positive
Blood creatinine decreased
Blood glucose decreased
Blood urea nitrogen/creatinine ratio decreased
Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)

30-39:

n/a

40-49:

Abdominal discomfort
Blood creatinine increased
Blood urea increased
Cough
Diarrhoea
Dysphagia (a condition in which swallowing is difficult or painful)
Dysuria (painful or difficult urination)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Impaired gastric emptying
Nausea (feeling of having an urge to vomit)

50-59:

Insomnia (sleeplessness)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Lung disorder (lung disease)
Lung infection
Malaise (a feeling of general discomfort or uneasiness)
Migraine (headache)
Multiple allergies (allergy to multiple agents)
Obesity (having too much body fat)
Oedema (fluid collection in tissue)
Polycystic ovaries (cysts in the ovaries that occurs when the follicle stops developing)

60+:

Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 6 people, 37.50%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 18.75%
Immunodeficiency Common Variable: 3 people, 18.75%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Dyspnea (difficult or laboured breathing): 2 people, 12.50%
Cough: 2 people, 12.50%
Pain: 2 people, 12.50%
Constipation: 2 people, 12.50%
Infection: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and Xopenex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously